Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Human Gene Therapy
|
August 20, 1996
Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase
R M Shull, X Lu, M F McEntee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
P B Robbins, D C Skelton, X J Yu, et al.
Leukemia
|
April 7, 1998
Immunotherapy against murine leukemia
S de Vos, D B Kohn, S K Cho, et al.
Gene Therapy
|
June 29, 2007
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors
T Higashimoto, F Urbinati, A Perumbeti, et al.
Human Gene Therapy
|
January 1, 1991
Toward gene therapy for Gaucher disease
D B Kohn, J A Nolta, J Weinthal, et al.
Human Gene Therapy
|
October 6, 1998
Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor
R Stripecke, D C Skelton, T Gruber, et al.
Gene Therapy
|
January 1, 1996
Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells
W J Krall, D C Skelton, X J Yu, et al.
Biotechniques
|
June 20, 2003
Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice
J S Burgos, M Rosol, R A Moats, et al.
Blood
|
July 9, 1999
Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors
G M Crooks, J Fuller, D Petersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Intrakines--evidence for a trans-cellular mechanism of action
B C Engel, G Bauer, K A Pepper, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Human Gene Therapy
|
August 20, 1996
Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase
R M Shull, X Lu, M F McEntee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
P B Robbins, D C Skelton, X J Yu, et al.
Leukemia
|
April 7, 1998
Immunotherapy against murine leukemia
S de Vos, D B Kohn, S K Cho, et al.
Gene Therapy
|
June 29, 2007
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors
T Higashimoto, F Urbinati, A Perumbeti, et al.
Human Gene Therapy
|
January 1, 1991
Toward gene therapy for Gaucher disease
D B Kohn, J A Nolta, J Weinthal, et al.
Human Gene Therapy
|
October 6, 1998
Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor
R Stripecke, D C Skelton, T Gruber, et al.
Gene Therapy
|
January 1, 1996
Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells
W J Krall, D C Skelton, X J Yu, et al.
Biotechniques
|
June 20, 2003
Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice
J S Burgos, M Rosol, R A Moats, et al.
Blood
|
July 9, 1999
Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors
G M Crooks, J Fuller, D Petersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Intrakines--evidence for a trans-cellular mechanism of action
B C Engel, G Bauer, K A Pepper, et al.
Page
of 12